Silk Road Medical Names Chas McKhann Chief Executive Officer
SUNNYVALE, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK) (“Silk Road” or the “Company”), a company focused on reducing the risk of stroke and its devastating impact, today announced that Chas McKhann has been appointed Chief Executive Officer (CEO), effective immediately.
- SUNNYVALE, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK) (“Silk Road” or the “Company”), a company focused on reducing the risk of stroke and its devastating impact, today announced that Chas McKhann has been appointed Chief Executive Officer (CEO), effective immediately.
- “Chas is a skilled and experienced leader with a track record of effectively building and scaling medical device businesses into underpenetrated markets.
- We are excited to welcome him to Silk Road,” said Jack Lasersohn, Chairman of the Board of Directors.
- Under his leadership, Silk Road remains committed to the same mission, vision, and values that have guided it since its founding.